EP3509585
TREATMENT OF SYMPTOMS RELATED TO NEURODEGENERATIVE DISORDERS THROUGH PHARMACOLOGICAL DERMAL ACTIVATION OF CRANIAL NERVES
:
EP einkaleyfi: Þýðing ekki lögð inn:
5.9.2017:
1.11.2023:
17849385.4
:
4.9.2037
:
TREATMENT OF SYMPTOMS RELATED TO NEURODEGENERATIVE DISORDERS THROUGH PHARMACOLOGICAL DERMAL ACTIVATION OF CRANIAL NERVES
5.9.2017
1.11.2023
:
Glia, LLC:
134 Saint Botolph Street, Boston, Massachusetts 02115-4819, US
:
CHANG, Wei-wei:
Boston, Massachusetts 02115, US
:
SAWYER, Kenneth I.:
Cushing, Maine 04563, US
:
201662384458 P:
7.9.2016:
US
:
US2017050055:
5.9.2017
:
A61K 31/352, A61P 25/00, A61K 31/57, A61K 9/00, A61K 31/164, A61K 31/473, A61K 31/565, A61K 31/568, A61K 31/573, A61K 45/06, A61P 21/02, A61P 25/16, A61P 25/28, A61P 27/02